The Editor in Chief, Dr Michael Spinella, is pleased to announce a new call for papers for Translational Oncogenomics. Submissions are being accepted now.
All authors who submit their manuscripts to Libertas will benefit from:
Convenient 3-step online manuscript submission
No space restrictions or color figure charges
Optional immediate publication on acceptance
Inclusion of your article in: Pubmed, Chemical Abstracts Service, Directory of Open Access Journals, EBSCO Academic Search Complete, EMBase, EMBiology, Google Scholar, Index Copernicus, OAlster, Open J-Gate, Pubmed Central, Socolar, EBSCO A-Z, HINARI, JournalSeek, OAJSE, Scirus, Ulrich's Periodicals
High readership and impact
Fast constructive peer review
Professional author service
All authors receive a comprehensive and fair peer review within just three weeks of submission. We make it as easy as possible for reviewers to do their work and ensure that they provide us with a fair, balanced and constructive assessment. This saves you time and means that their expert comments will help you to improve your work.
Libertas staff will provide you with frequent updates on your submission by email or through your My LA user account. Staff are even available for you to chat live with on our instant chat service.
Translational Oncogenomics is designed to provide high visibility for your paper. Since 2007, articles in Translational Oncogenomics have been viewed 83,082 times. To maximise your paper’s visibility, your article will be announced on Twitter, Tumblr, RSS, LinkedIn, BlogSpot, Facebook, and by email newsletters.
On acceptance of your manuscript, Libertas’ efficient and user-friendly interface will guide you through the production process. Your paper will be published as soon as it is ready. We also offer copy editing, figure creation and provisional PDF publication services.
The submission process takes under two minutes and processing will commence on the same day.
Posts
